Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The opportunistic intestinal pathogens and microbiota ecosystem refers to the complex community of microorganisms residing in the human gastrointestinal tract and the specific pathogenic species that exploit disruptions in this community. The gut microbiota provides essential functions including nutrient metabolism, immune system modulation, and protection against pathogen colonization through a process known as colonization resistance (NIH). When this ecosystem is disturbed—often by broad-spectrum antibiotic use—opportunistic pathogens such as Clostridioides difficile or Vancomycin-resistant Enterococci (VRE) can proliferate, leading to severe enteric infections and systemic inflammation (PubMed). Therapeutic strategies targeting this ecosystem focus on either the eradication of specific pathogens using antibiotics or the restoration of a healthy microbial balance through probiotics and fecal microbiota transplantation (FMT) (FDA). This target is considered incorrect in a classical pharmacological sense because it represents a multi-organism ecological system rather than a single protein, receptor, or enzyme.
Restoration of microbial diversity, competitive exclusion of pathogens, and inhibition of bacterial cell wall synthesis or protein synthesis.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Opportunistic intestinal pathogens and microbiota ecosystem.